microRNA information: hsa-miR-9-5p

SectionIDlink
Mature name: hsa-miR-9-5pmiRbase
Accession: MIMAT0000441miRbase
Precursor name: hsa-mir-9-1 miRbase
Precursor accession: MI0000466miRbase
Symbol: MIR9-1HGNC
RefSeq ID: NR_029691GenBank
Sequence: UCUUUGGUUAUCUAGCUGUAUGA



Reported expression in cancers: hsa-miR-9-5p

miRNAcancerregulationreportingPUBMEDmethod
hsa-miR-9-5p

acute myeloid leukemiaupregulation"By multivariate analysis we identified that high e ......"25428263
hsa-miR-9-5p

bladder cancerupregulation"The present study aims to identify the expression ......"26150338
hsa-miR-9-5p

breast cancerupregulation"Some miRNAs especially the miR-200 family miR-9 an ......"25086633qPCR
hsa-miR-9-5p

breast cancerdownregulation"Aberrant expression of miR 9 in benign and maligna ......"27725294qPCR
hsa-miR-9-5p

cervical and endocervical cancerupregulation"Molecular identification of miR 145 and miR 9 expr ......"27345415qPCR
hsa-miR-9-5p

colon cancerdownregulation"Among the miRNAs demonstrating the largest fold up ......"21694772
hsa-miR-9-5p

colon cancerdownregulation"To present proof-of-principle application for empl ......"23741026qPCR; Microarray
hsa-miR-9-5p

colorectal cancerderegulation"Real time-polymerase chain reaction was used to an ......"26867319qPCR
hsa-miR-9-5p

esophageal cancerupregulation"Deregulation of MicroRNA-9 miR-9 has been document ......"25375090
hsa-miR-9-5p

gastric cancerdownregulation"Down regulated miR 9 and miR 433 in human gastric ......"19531230qPCR
hsa-miR-9-5p

gastric cancerdownregulation"Aberrant hypermethylation of miR 9 genes in gastri ......"21931274
hsa-miR-9-5p

gastric cancerdownregulation"Compared with the expression levels in the normal ......"25013480
hsa-miR-9-5p

gastric cancerdownregulation"Real-time quantitative PCR RTQ-PCR was employed to ......"25270964qPCR
hsa-miR-9-5p

liver cancerupregulation"Up regulation of miR 9 expression predicate advanc ......"25552204qPCR
hsa-miR-9-5p

liver cancerdownregulation"MicroRNA-9 miR-9 dysregulation is implicated in a ......"26547929Microarray; qPCR
hsa-miR-9-5p

lung cancerderegulation"Therefore we conduct to systematically identify mi ......"26870998Microarray
hsa-miR-9-5p

lung squamous cell cancerupregulation"Up regulation of miR 9 expression as a poor progno ......"24019037qPCR
hsa-miR-9-5p

melanomadownregulation"Hsa-miR-9 has been shown to have opposite function ......"22131135
hsa-miR-9-5p

ovarian cancerdownregulation"Ovarian cancer tissues display significantly low e ......"19702828
hsa-miR-9-5p

ovarian cancerdownregulation"Methylation associated Has miR 9 deregulation in p ......"26152689
hsa-miR-9-5p

prostate cancerupregulation"Significantly a subset of miRNAs miR-9 miR-25 miR- ......"24135225



Reported cancer pathway affected by hsa-miR-9-5p

miRNAcancerpathwayreportingPUBMEDfunctional study
hsa-miR-9-5p

acute myeloid leukemiaApoptosis pathway"Our results showed that the level of either Hes1 o ......"26678889
hsa-miR-9-5p

bladder cancerApoptosis pathway; cell cycle pathway"miR 9 promotes cell proliferation and inhibits apo ......"26150338Luciferase
hsa-miR-9-5p

breast cancerEpithelial mesenchymal transition pathway"Global miRNA expression profiling was performed on ......"22294488
hsa-miR-9-5p

breast cancerEpithelial mesenchymal transition pathway"Some miRNAs especially the miR-200 family miR-9 an ......"25086633
hsa-miR-9-5p

breast cancerApoptosis pathway"Based on the results obtained in the last decade s ......"26199650
hsa-miR-9-5p

breast cancercell cycle pathway"Performing qPCR we identified eight miRs different ......"27152840
hsa-miR-9-5p

breast cancerp53 signaling pathway"Aberrant expression of miR 9 in benign and maligna ......"27725294
hsa-miR-9-5p

colon cancerEpithelial mesenchymal transition pathway"Prospero homeobox 1 promotes epithelial mesenchyma ......"23045246
hsa-miR-9-5p

colorectal cancerApoptosis pathway"Here we showed that compared with corresponding no ......"25940709Luciferase
hsa-miR-9-5p

esophageal cancerEpithelial mesenchymal transition pathway"Deregulation of MicroRNA-9 miR-9 has been document ......"25375090
hsa-miR-9-5p

gastric cancerHippo signaling pathway"Cullin 4A CUL4A a direct target of miR 9 and miR 1 ......"26840256
hsa-miR-9-5p

liver cancerApoptosis pathway"Long noncoding RNA ZNFX1 AS1 suppresses growth of ......"27574442MTT assay; Colony formation
hsa-miR-9-5p

lung cancerEpithelial mesenchymal transition pathway"Specifically let-7 and miR-9 are deregulated in bo ......"23365639
hsa-miR-9-5p

lung cancercell cycle pathway"MIR 142 5p and miR 9 may be involved in squamous l ......"24338464
hsa-miR-9-5p

lung squamous cell cancerApoptosis pathway"Demethylation of miR 9 3 and miR 193a genes suppre ......"24356455Flow cytometry; Western blot
hsa-miR-9-5p

lung squamous cell cancerEpithelial mesenchymal transition pathway"miR-9 family members miR-9s including miR-9-1 9-2 ......"24649145
hsa-miR-9-5p

lymphomaApoptosis pathway"Expression pattern of hsa miR 9 and its associatio ......"23688983Western blot; Flow cytometry
hsa-miR-9-5p

melanomacell cycle pathway"Quantitative RT-PCR analysis was used to determine ......"26104682Luciferase
hsa-miR-9-5p

ovarian cancerApoptosis pathway"SKOV3 ovarian cancer cells were treated with curcu ......"24870723Western blot
hsa-miR-9-5p

sarcomaApoptosis pathway; Epithelial mesenchymal transition pathway"17β estradiol regulates cell proliferation colony ......"25592968Colony formation
hsa-miR-9-5p

sarcomaApoptosis pathway"MiR 9 is overexpressed in spontaneous canine osteo ......"27724924Western blot



Reported cancer prognosis affected by hsa-miR-9-5p

miRNAcancerprognosisreportingPUBMEDfunctional study
hsa-miR-9-5p

acute myeloid leukemiapoor survival"Our results showed that the level of either Hes1 o ......"26678889
hsa-miR-9-5p

bladder cancerstaging; poor survival; recurrence"Expression levels of miRNAs were assessed by quant ......"23169479
hsa-miR-9-5p

bladder cancerprogression; drug resistance; malignant trasformation"miR 9 promotes cell proliferation and inhibits apo ......"26150338Luciferase
hsa-miR-9-5p

bladder cancerdrug resistance"Focusing on the major obstacle regarding MIBC pati ......"27586262
hsa-miR-9-5p

breast cancermetastasis; staging; progression"Global miRNA expression profiling was performed on ......"22294488
hsa-miR-9-5p

breast cancermetastasis"The clinico pathologic role of microRNAs miR 9 and ......"22489664
hsa-miR-9-5p

breast cancerpoor survival"Eight candidate miRs that showed significant diffe ......"22723919
hsa-miR-9-5p

breast cancermetastasis"The aim of this study was to investigate the relat ......"23617747
hsa-miR-9-5p

breast cancermetastasis"In this study we explored whether FOXO1 3'UTR can ......"25017439
hsa-miR-9-5p

breast cancerpoor survival; progression; worse prognosis"Some miRNAs especially the miR-200 family miR-9 an ......"25086633
hsa-miR-9-5p

breast cancerdrug resistance"Besides several miRNAs e.g miR-375 were enriched i ......"25680412
hsa-miR-9-5p

breast cancermetastasis; worse prognosis; drug resistance"Based on the results obtained in the last decade s ......"26199650
hsa-miR-9-5p

breast cancerdifferentiation"miR 9 and miR 200 Regulate PDGFRβ Mediated Endoth ......"27402080
hsa-miR-9-5p

breast cancermalignant trasformation; progression"Aberrant expression of miR 9 in benign and maligna ......"27725294
hsa-miR-9-5p

cervical and endocervical cancerpoor survival"Using an established PCR-based miRNA assay to anal ......"20124485
hsa-miR-9-5p

cervical and endocervical cancercell migration; motility"Activation of miR 9 by human papillomavirus in cer ......"25344913
hsa-miR-9-5p

cervical and endocervical cancerstaging; metastasis; poor survival"Molecular identification of miR 145 and miR 9 expr ......"27345415
hsa-miR-9-5p

colon cancerpoor survival; tumorigenesis"MiR 9 31 and 182 deregulation promote proliferatio ......"23019418
hsa-miR-9-5p

colon cancerstaging"To present proof-of-principle application for empl ......"23741026
hsa-miR-9-5p

colorectal cancermetastasis"Treatment with a DNA methyltransferase inhibitor a ......"19521961
hsa-miR-9-5p

colorectal cancermetastasis; motility"Human microRNA-9 miR-9 has been reported to be inv ......"21562850Cell migration assay; Western blot
hsa-miR-9-5p

colorectal cancermetastasis"We analyzed 60 colon cancers and paired normal spe ......"26983891Luciferase
hsa-miR-9-5p

endometrial cancermalignant trasformation"Expression profiling of normal and malignant endom ......"20028871
hsa-miR-9-5p

esophageal cancermetastasis; progression; poor survival; cell migration"Deregulation of MicroRNA-9 miR-9 has been document ......"25375090
hsa-miR-9-5p

gastric cancerprogression"Aberrant hypermethylation of miR 9 genes in gastri ......"21931274
hsa-miR-9-5p

gastric cancerprogression; metastasis"Recent evidence shows that altered microRNA-9 miR- ......"23383271Luciferase
hsa-miR-9-5p

gastric cancerstaging; worse prognosis"Overexpression of activated leukocute cell adhesio ......"25395097
hsa-miR-9-5p

glioblastomadifferentiation"Foremost among these is miR-9 which suppresses mes ......"21385897
hsa-miR-9-5p

glioblastomadrug resistance"Computational studies real-time PCR reporter gene ......"25595896Western blot
hsa-miR-9-5p

glioblastomametastasis; worse prognosis"hsa miR 9 controls the mobility behavior of gliobl ......"27036038
hsa-miR-9-5p

glioblastomadrug resistance"High expression of miR 9 in CD133+ glioblastoma ce ......"27347493
hsa-miR-9-5p

kidney renal cell cancerrecurrence; poor survival"Hsa miR 9 methylation status is associated with ca ......"20676129
hsa-miR-9-5p

liver cancermetastasis"Identification of metastasis related microRNAs of ......"19912688
hsa-miR-9-5p

liver cancercell migration"There was also a significantly higher expression o ......"23684102
hsa-miR-9-5p

liver cancerstaging; worse prognosis; poor survival"Up regulation of miR 9 expression predicate advanc ......"25552204
hsa-miR-9-5p

liver cancerpoor survival"Among the seven significant miRNAs six hsa-mir-326 ......"26046780
hsa-miR-9-5p

liver cancertumor size; progression"MicroRNA-9 miR-9 dysregulation is implicated in a ......"26547929Western blot; Luciferase
hsa-miR-9-5p

liver cancerprogression; tumorigenesis; worse prognosis; malignant trasformation; poor survival"MicroRNA-9 miR-9 is known to play an important rol ......"26770365Western blot
hsa-miR-9-5p

liver cancerprogression"Long noncoding RNA ZNFX1 AS1 suppresses growth of ......"27574442MTT assay; Colony formation
hsa-miR-9-5p

lung cancermetastasis"Moreover expression levels of 84 tumor metastasis- ......"23296057
hsa-miR-9-5p

lung squamous cell cancerstaging; malignant trasformation"Genome wide miRNA expression profiling identifies ......"22282464
hsa-miR-9-5p

lung squamous cell cancerworse prognosis; staging; metastasis; tumor size; progression; poor survival"Up regulation of miR 9 expression as a poor progno ......"24019037
hsa-miR-9-5p

lung squamous cell cancerpoor survival"miR-9 family members miR-9s including miR-9-1 9-2 ......"24649145
hsa-miR-9-5p

lung squamous cell cancermetastasis"The differentially expressed microRNAs associated ......"25628919
hsa-miR-9-5p

lung squamous cell cancermetastasis"Expression of miR-9 miR-10b miR-145 and miR-155 4 ......"26909466
hsa-miR-9-5p

lung squamous cell cancerdrug resistance"Associating drug response with micro-RNA expressio ......"27247353
hsa-miR-9-5p

melanomametastasis; progression"Hsa-miR-9 has been shown to have opposite function ......"22131135
hsa-miR-9-5p

melanomametastasis; cell migration"MicroRNAs miRNAs have been implicated in the regul ......"22825752
hsa-miR-9-5p

melanomametastasis"Six microRNAs miR-9 miR-145 miR-150 miR-155 miR-20 ......"23863473
hsa-miR-9-5p

melanomaprogression"Quantitative RT-PCR analysis was used to determine ......"26104682Luciferase
hsa-miR-9-5p

ovarian cancerpoor survival"Deregulated miRNAs identified by miRNA microarray ......"23627607Western blot; Luciferase
hsa-miR-9-5p

ovarian cancermetastasis; progression"miR 9 functions as a tumor suppressor in ovarian s ......"23722670
hsa-miR-9-5p

ovarian cancerworse prognosis; progression; poor survival; drug resistance"miR 9 regulation of BRCA1 and ovarian cancer sensi ......"24168967Luciferase
hsa-miR-9-5p

ovarian cancertumorigenesis"By performing real-time polymerase chain reaction ......"25846738
hsa-miR-9-5p

ovarian cancerstaging; poor survival; drug resistance"Methylation associated Has miR 9 deregulation in p ......"26152689Western blot; Luciferase; RNAi
hsa-miR-9-5p

prostate cancermetastasis; progression"miR 9 Acts as an OncomiR in Prostate Cancer throug ......"27447934
hsa-miR-9-5p

sarcomaworse prognosis; staging; metastasis; tumor size; poor survival; progression"The purpose of the present study was to examine th ......"24969351
hsa-miR-9-5p

sarcomamalignant trasformation"MiR 9 is overexpressed in spontaneous canine osteo ......"27724924Western blot
hsa-miR-9-5p

thyroid cancerrecurrence"MiR 9 and miR 21 as prognostic biomarkers for recu ......"26007293



Reported gene related to hsa-miR-9-5p

miRNAcancergenereportingPUBMED
hsa-miR-9-5p

breast cancerCDH1"Expression of miR-9 was also higher in tumors show ......"25086633
hsa-miR-9-5p

breast cancerCDH1"We investigated the expressions of miR-9 and miR-2 ......"23617747
hsa-miR-9-5p

colon cancerCDH1"Prospero homeobox 1 promotes epithelial mesenchyma ......"23045246
hsa-miR-9-5p

esophageal cancerCDH1"Taken together our study demonstrates that miR-9 p ......"25375090
hsa-miR-9-5p

lung squamous cell cancerCDH1"miR-9 family members miR-9s including miR-9-1 9-2 ......"24649145
hsa-miR-9-5p

melanomaCDH1"miR-9 overexpression induced significant down-regu ......"22131135
hsa-miR-9-5p

prostate cancerCDH1"Analysis showed that miR-9 targets e-cadherin and ......"27447934
hsa-miR-9-5p

sarcomaCDH1"Transient transfection of RMS cells with a miR-200 ......"23000453
hsa-miR-9-5p

lung cancerDICER1"A modest decrease in Drosha and Dicer mRNA levels ......"23296057
hsa-miR-9-5p

lymphomaDICER1"Inhibition of miR 9 de represses HuR and DICER1 an ......"22310293
hsa-miR-9-5p

breast cancerFOXO1"In this study we explored whether FOXO1 3'UTR can ......"25017439
hsa-miR-9-5p

ovarian cancerFOXO1"Phosphorylation of Akt and forkhead box protein O1 ......"24870723
hsa-miR-9-5p

gastric cancerRAB34"GRB2 and RAB34 targets of miR-433 and miR-9 respec ......"19531230
hsa-miR-9-5p

ovarian cancerRAB34"RAB34 was validated as a direct target of miR-9 ......"23627607
hsa-miR-9-5p

liver cancerTLN1"Talin-1 which plays a significant role in regulati ......"26770365
hsa-miR-9-5p

ovarian cancerTLN1"miR 9 functions as a tumor suppressor in ovarian s ......"23722670
hsa-miR-9-5p

glioblastomaABCG2"MiR-9 mediated increases in the drug efflux transp ......"25595896
hsa-miR-9-5p

bladder cancerBCL2"LASS2 transfection downregulated Bcl-2 and survivi ......"26150338
hsa-miR-9-5p

lymphomaBCL6"Expression pattern of hsa miR 9 and its associatio ......"23688983
hsa-miR-9-5p

ovarian cancerBRCA1"miR 9 regulation of BRCA1 and ovarian cancer sensi ......"24168967
hsa-miR-9-5p

ovarian cancerCASP3"In contrast overexpression of miR-9 significantly ......"24870723
hsa-miR-9-5p

lung cancerCCL21"Besides MIR-142-5p and miR-9 may be utilized to tr ......"24338464
hsa-miR-9-5p

breast cancerCCL27"Interestingly miR-9 levels were elevated in invasi ......"22489664
hsa-miR-9-5p

sarcomaCCNDBP1"miR 9 Modulates Osteosarcoma Cell Growth by Target ......"26107195
hsa-miR-9-5p

ovarian cancerCCNG1"CCNG1 validated as a direct target of miR-9 mediat ......"26152689
hsa-miR-9-5p

gastric cancerCDX2"MiR 9 downregulates CDX2 expression in gastric can ......"21225631
hsa-miR-9-5p

bladder cancerCERS2"miR 9 promotes cell proliferation and inhibits apo ......"26150338
hsa-miR-9-5p

B cell lymphomaCHRDL1"To investigate the expression of miR-9 in B lympho ......"21569708
hsa-miR-9-5p

gastric cancerCUL4A"Interestingly CUL4A expression was inhibited by th ......"26840256
hsa-miR-9-5p

lung cancerDROSHA"A modest decrease in Drosha and Dicer mRNA levels ......"23296057
hsa-miR-9-5p

lung cancerEGFR"We elected to validate our model in vitro by testi ......"23365639
hsa-miR-9-5p

lymphomaELAVL1"Inhibition of miR 9 de represses HuR and DICER1 an ......"22310293
hsa-miR-9-5p

breast cancerESR1"Higher expression of miR-9 was significantly assoc ......"22723919
hsa-miR-9-5p

glioblastomaFOXP1"Silencing of FOXP1 a miR-9 target inhibits ΔEGFR- ......"24436148
hsa-miR-9-5p

gastric cancerGRB2"GRB2 and RAB34 targets of miR-433 and miR-9 respec ......"19531230
hsa-miR-9-5p

sarcomaGSN"Proteomic and transcriptional profiling of normal ......"27724924
hsa-miR-9-5p

acute myeloid leukemiaHES1"Our results showed that the level of either Hes1 o ......"26678889
hsa-miR-9-5p

lymphomaHGS"Our studies here demonstrate that PRDM1/blimp-1 is ......"18583325
hsa-miR-9-5p

lymphomaHOXB7"This included NFκB1 and hsa-miR-9 hsa-miR-196a-1 ......"24145479
hsa-miR-9-5p

gastric cancerIBSP"Bisulfite genomic sequencing PCR BSP was performed ......"25270964
hsa-miR-9-5p

prostate cancerICA1"miR-9 was identified as an oncomiR through both mi ......"27447934
hsa-miR-9-5p

ovarian cancerIGKV2D-40"Phosphorylation of Akt and forkhead box protein O1 ......"24870723
hsa-miR-9-5p

liver cancerKLF17"In addition miR-9 downregulated KLF17 protein expr ......"23684102
hsa-miR-9-5p

ovarian cancerLSS"The downregulation of microRNA-9 miR-9 has been re ......"23722670
hsa-miR-9-5p

sarcomaMALAT1"The observation of upregulation of miR-9 after a h ......"25592968
hsa-miR-9-5p

glioblastomaMAPK14"hsa miR 9 controls the mobility behavior of gliobl ......"27036038
hsa-miR-9-5p

breast cancerMTHFD2"Among these MTHFD2 was identified as a miR-9 targe ......"22761433
hsa-miR-9-5p

lung cancerMYC"We elected to validate our model in vitro by testi ......"23365639
hsa-miR-9-5p

lung cancerNKIRAS1"Besides a statistically significant negative corre ......"23156677
hsa-miR-9-5p

ovarian cancerPARP1"In contrast overexpression of miR-9 significantly ......"24870723
hsa-miR-9-5p

colon cancerPROX1"Prospero homeobox 1 promotes epithelial mesenchyma ......"23045246
hsa-miR-9-5p

glioblastomaPTCH1"Computational studies real-time PCR reporter gene ......"25595896
hsa-miR-9-5p

melanomaRYBP"Finally the post-transcriptional regulation of miR ......"26104682
hsa-miR-9-5p

glioblastomaSHH"Computational studies real-time PCR reporter gene ......"25595896
hsa-miR-9-5p

melanomaSNAI1"miR-9 overexpression induced significant down-regu ......"22131135
hsa-miR-9-5p

prostate cancerSOCS5"Analysis showed that miR-9 targets e-cadherin and ......"27447934
hsa-miR-9-5p

glioblastomaSTAT3"Foremost among these is miR-9 which suppresses mes ......"21385897
hsa-miR-9-5p

liver cancerTAZ"miR 9 3p plays a tumour suppressor role by targeti ......"26125451
hsa-miR-9-5p

lung squamous cell cancerTGFBR2"Follow-up experiments showed two miRNAs miR-9-5p a ......"25024357
hsa-miR-9-5p

colorectal cancerTM4SF1"We analyzed 60 colon cancers and paired normal spe ......"26983891
hsa-miR-9-5p

breast cancerTP53"Furthermore pathways in cancer p53 signaling pathw ......"27725294
hsa-miR-9-5p

colorectal cancerUHRF1"Here we showed that compared with corresponding no ......"25940709
hsa-miR-9-5p

breast cancerVIM"Expression of miR-9 was also higher in tumors show ......"25086633
hsa-miR-9-5p

liver cancerWWTR1"miR 9 3p plays a tumour suppressor role by targeti ......"26125451
hsa-miR-9-5p

melanomaYY1"Quantitative RT-PCR analysis was used to determine ......"26104682
hsa-miR-9-5p

liver cancerZFAS1"Finally the relationship between ZNFX1-AS1 and miR ......"27574442



Expression profile in cancer corhorts:




Putative target regulations

miRNAGeneCancerInteractionCorrelation beta
hsa-miR-9-5p
CD34
11 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LGG; LUAD; LUSC; PRAD; SARC; UCEC
miRNAWalker2 validate
TCGA BLCA -0.092; TCGA BRCA -0.112; TCGA CESC -0.06; TCGA ESCA -0.106; TCGA KIRC -0.068; TCGA LGG -0.328; TCGA LUAD -0.136; TCGA LUSC -0.265; TCGA PRAD -0.056; TCGA SARC -0.093; TCGA UCEC -0.061
hsa-miR-9-5p
CXXC5
10 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LUSC; OV; THCA; UCEC
miRNAWalker2 validate
TCGA BLCA -0.104; TCGA BRCA -0.144; TCGA ESCA -0.136; TCGA HNSC -0.121; TCGA KIRP -0.054; TCGA LGG -0.138; TCGA LUSC -0.128; TCGA OV -0.106; TCGA THCA -0.124; TCGA UCEC -0.161
hsa-miR-9-5p
ETS1
10 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PRAD; UCEC
miRNAWalker2 validate; miRTarBase; miRNATAP
TCGA BLCA -0.102; TCGA CESC -0.109; TCGA ESCA -0.159; TCGA HNSC -0.142; TCGA KIRC -0.094; TCGA LUAD -0.097; TCGA LUSC -0.293; TCGA OV -0.099; TCGA PRAD -0.093; TCGA UCEC -0.078
hsa-miR-9-5p
FLNB
9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; OV; PAAD; STAD
miRNAWalker2 validate
TCGA BLCA -0.082; TCGA BRCA -0.063; TCGA CESC -0.063; TCGA ESCA -0.158; TCGA HNSC -0.119; TCGA LGG -0.224; TCGA OV -0.069; TCGA PAAD -0.189; TCGA STAD -0.125
hsa-miR-9-5p
FOXO1
10 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PRAD; UCEC
miRNAWalker2 validate; miRTarBase; miRNATAP
TCGA BLCA -0.082; TCGA BRCA -0.099; TCGA HNSC -0.109; TCGA LGG -0.239; TCGA LIHC -0.16; TCGA LUAD -0.121; TCGA LUSC -0.102; TCGA OV -0.076; TCGA PRAD -0.058; TCGA UCEC -0.091
hsa-miR-9-5p
FSTL3
11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LUAD; LUSC; OV; THCA; UCEC
miRNAWalker2 validate
TCGA BLCA -0.109; TCGA BRCA -0.167; TCGA CESC -0.089; TCGA HNSC -0.224; TCGA KIRC -0.078; TCGA LGG -0.277; TCGA LUAD -0.086; TCGA LUSC -0.26; TCGA OV -0.139; TCGA THCA -0.148; TCGA UCEC -0.169
hsa-miR-9-5p
HLA-A
9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; SARC
miRNAWalker2 validate
TCGA BLCA -0.06; TCGA CESC -0.114; TCGA ESCA -0.135; TCGA HNSC -0.1; TCGA KIRC -0.135; TCGA KIRP -0.082; TCGA LGG -0.353; TCGA LUSC -0.128; TCGA SARC -0.158
hsa-miR-9-5p
KCNJ15
9 cancers: BLCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; THCA
miRNAWalker2 validate
TCGA BLCA -0.141; TCGA HNSC -0.317; TCGA KIRC -0.137; TCGA KIRP -0.071; TCGA LUAD -0.216; TCGA LUSC -0.275; TCGA PRAD -0.182; TCGA SARC -0.189; TCGA THCA -0.085
hsa-miR-9-5p
KLRK1
9 cancers: BLCA; BRCA; CESC; KIRC; LUAD; LUSC; OV; SARC; UCEC
miRNAWalker2 validate
TCGA BLCA -0.126; TCGA BRCA -0.052; TCGA CESC -0.173; TCGA KIRC -0.12; TCGA LUAD -0.056; TCGA LUSC -0.237; TCGA OV -0.212; TCGA SARC -0.249; TCGA UCEC -0.168
hsa-miR-9-5p
LPXN
9 cancers: BLCA; CESC; ESCA; KIRC; LGG; LUAD; LUSC; OV; SARC
miRNAWalker2 validate
TCGA BLCA -0.107; TCGA CESC -0.084; TCGA ESCA -0.086; TCGA KIRC -0.053; TCGA LGG -0.197; TCGA LUAD -0.1; TCGA LUSC -0.276; TCGA OV -0.086; TCGA SARC -0.151
hsa-miR-9-5p
MYLK
9 cancers: BLCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PRAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.171; TCGA HNSC -0.067; TCGA LGG -0.718; TCGA LIHC -0.104; TCGA LUAD -0.1; TCGA LUSC -0.193; TCGA OV -0.096; TCGA PRAD -0.143; TCGA UCEC -0.12
hsa-miR-9-5p
OPTN
10 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; SARC; UCEC
miRNAWalker2 validate; MirTarget
TCGA BLCA -0.067; TCGA CESC -0.09; TCGA ESCA -0.087; TCGA HNSC -0.114; TCGA KIRC -0.059; TCGA KIRP -0.068; TCGA LGG -0.229; TCGA LUSC -0.078; TCGA SARC -0.12; TCGA UCEC -0.141
hsa-miR-9-5p
POU2F2
9 cancers: BLCA; CESC; ESCA; KIRC; LGG; LUSC; PRAD; SARC; UCEC
miRNAWalker2 validate; mirMAP; miRNATAP
TCGA BLCA -0.092; TCGA CESC -0.084; TCGA ESCA -0.087; TCGA KIRC -0.088; TCGA LGG -0.249; TCGA LUSC -0.154; TCGA PRAD -0.114; TCGA SARC -0.115; TCGA UCEC -0.08
hsa-miR-9-5p
PQLC3
11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUSC; OV; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.076; TCGA BRCA -0.083; TCGA CESC -0.065; TCGA ESCA -0.08; TCGA HNSC -0.06; TCGA LGG -0.674; TCGA LUSC -0.084; TCGA OV -0.065; TCGA SARC -0.059; TCGA STAD -0.084; TCGA UCEC -0.075
hsa-miR-9-5p
SLC22A3
9 cancers: BLCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; OV; UCEC
miRNAWalker2 validate
TCGA BLCA -0.188; TCGA CESC -0.212; TCGA ESCA -0.264; TCGA HNSC -0.445; TCGA LIHC -0.171; TCGA LUAD -0.286; TCGA LUSC -0.48; TCGA OV -0.12; TCGA UCEC -0.235
hsa-miR-9-5p
SPI1
10 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; SARC; UCEC
miRNAWalker2 validate
TCGA BLCA -0.132; TCGA HNSC -0.062; TCGA KIRC -0.138; TCGA KIRP -0.074; TCGA LGG -0.401; TCGA LUAD -0.105; TCGA LUSC -0.308; TCGA OV -0.143; TCGA SARC -0.239; TCGA UCEC -0.06
hsa-miR-9-5p
SYNE1
9 cancers: BLCA; BRCA; CESC; HNSC; LUAD; LUSC; OV; PRAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.148; TCGA BRCA -0.087; TCGA CESC -0.132; TCGA HNSC -0.104; TCGA LUAD -0.162; TCGA LUSC -0.394; TCGA OV -0.083; TCGA PRAD -0.085; TCGA UCEC -0.161
hsa-miR-9-5p
TAGLN
9 cancers: BLCA; BRCA; CESC; HNSC; LGG; LUSC; OV; SARC; UCEC
miRNAWalker2 validate
TCGA BLCA -0.203; TCGA BRCA -0.061; TCGA CESC -0.113; TCGA HNSC -0.096; TCGA LGG -0.419; TCGA LUSC -0.227; TCGA OV -0.246; TCGA SARC -0.194; TCGA UCEC -0.156
hsa-miR-9-5p
TC2N
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUSC; OV; STAD
miRNAWalker2 validate
TCGA BLCA -0.075; TCGA BRCA -0.112; TCGA CESC -0.124; TCGA COAD -0.095; TCGA ESCA -0.186; TCGA LGG -1.288; TCGA LUSC -0.067; TCGA OV -0.129; TCGA STAD -0.158
hsa-miR-9-5p
SGMS2
14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD
MirTarget; miRNATAP
TCGA BLCA -0.092; TCGA CESC -0.092; TCGA COAD -0.094; TCGA ESCA -0.162; TCGA HNSC -0.169; TCGA KIRP -0.067; TCGA LGG -1.351; TCGA LUAD -0.15; TCGA LUSC -0.353; TCGA OV -0.182; TCGA PAAD -0.105; TCGA PRAD -0.091; TCGA SARC -0.127; TCGA STAD -0.105
hsa-miR-9-5p
CRIM1
12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; OV; PRAD; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.086; TCGA BRCA -0.076; TCGA CESC -0.144; TCGA ESCA -0.103; TCGA HNSC -0.134; TCGA LGG -0.323; TCGA LUAD -0.078; TCGA LUSC -0.113; TCGA OV -0.066; TCGA PRAD -0.104; TCGA STAD -0.07; TCGA UCEC -0.119
hsa-miR-9-5p
SLC31A2
9 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; SARC
MirTarget
TCGA BLCA -0.075; TCGA BRCA -0.054; TCGA HNSC -0.2; TCGA KIRC -0.099; TCGA KIRP -0.081; TCGA LGG -0.361; TCGA LUAD -0.081; TCGA LUSC -0.217; TCGA SARC -0.146
hsa-miR-9-5p
TINAGL1
12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD
MirTarget
TCGA BLCA -0.142; TCGA CESC -0.158; TCGA COAD -0.118; TCGA ESCA -0.136; TCGA HNSC -0.057; TCGA LIHC -0.092; TCGA LUAD -0.067; TCGA LUSC -0.113; TCGA PRAD -0.088; TCGA SARC -0.127; TCGA THCA -0.091; TCGA STAD -0.094
hsa-miR-9-5p
UBL3
9 cancers: BLCA; BRCA; CESC; ESCA; LIHC; LUAD; LUSC; OV; THCA
MirTarget
TCGA BLCA -0.056; TCGA BRCA -0.086; TCGA CESC -0.091; TCGA ESCA -0.071; TCGA LIHC -0.055; TCGA LUAD -0.1; TCGA LUSC -0.178; TCGA OV -0.105; TCGA THCA -0.065
hsa-miR-9-5p
PDK4
10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; THCA; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.112; TCGA BRCA -0.241; TCGA CESC -0.152; TCGA ESCA -0.282; TCGA HNSC -0.201; TCGA LIHC -0.154; TCGA LUAD -0.176; TCGA LUSC -0.5; TCGA THCA -0.154; TCGA UCEC -0.108
hsa-miR-9-5p
ITM2B
9 cancers: BLCA; BRCA; HNSC; LGG; LUAD; LUSC; OV; SARC; UCEC
MirTarget
TCGA BLCA -0.102; TCGA BRCA -0.09; TCGA HNSC -0.076; TCGA LGG -0.109; TCGA LUAD -0.093; TCGA LUSC -0.096; TCGA OV -0.081; TCGA SARC -0.088; TCGA UCEC -0.112
hsa-miR-9-5p
IL33
9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; SARC
MirTarget
TCGA BLCA -0.246; TCGA BRCA -0.199; TCGA ESCA -0.219; TCGA HNSC -0.247; TCGA KIRC -0.055; TCGA LUAD -0.233; TCGA LUSC -0.471; TCGA PRAD -0.138; TCGA SARC -0.175
hsa-miR-9-5p
DENND3
10 cancers: BLCA; CESC; ESCA; KIRC; LGG; LUAD; LUSC; OV; SARC; UCEC
MirTarget
TCGA BLCA -0.063; TCGA CESC -0.129; TCGA ESCA -0.111; TCGA KIRC -0.073; TCGA LGG -0.433; TCGA LUAD -0.107; TCGA LUSC -0.28; TCGA OV -0.144; TCGA SARC -0.096; TCGA UCEC -0.154
hsa-miR-9-5p
SHROOM4
11 cancers: BLCA; BRCA; CESC; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; THCA; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.145; TCGA BRCA -0.094; TCGA CESC -0.1; TCGA HNSC -0.063; TCGA LGG -0.215; TCGA LIHC -0.058; TCGA LUAD -0.222; TCGA LUSC -0.342; TCGA PRAD -0.119; TCGA THCA -0.259; TCGA UCEC -0.065
hsa-miR-9-5p
MEF2C
10 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PRAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.089; TCGA BRCA -0.051; TCGA HNSC -0.161; TCGA KIRC -0.086; TCGA LGG -0.317; TCGA LUAD -0.121; TCGA LUSC -0.285; TCGA OV -0.097; TCGA PRAD -0.103; TCGA UCEC -0.112
hsa-miR-9-5p
PMP22
9 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LUAD; LUSC; OV; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.11; TCGA BRCA -0.112; TCGA ESCA -0.108; TCGA HNSC -0.084; TCGA LGG -0.418; TCGA LUAD -0.11; TCGA LUSC -0.252; TCGA OV -0.149; TCGA UCEC -0.085
hsa-miR-9-5p
TPK1
11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.134; TCGA BRCA -0.089; TCGA CESC -0.165; TCGA ESCA -0.254; TCGA HNSC -0.064; TCGA LGG -0.264; TCGA LUAD -0.163; TCGA LUSC -0.255; TCGA SARC -0.055; TCGA STAD -0.074; TCGA UCEC -0.145
hsa-miR-9-5p
NOX4
11 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LGG; OV; SARC; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.081; TCGA BRCA -0.095; TCGA CESC -0.083; TCGA KIRC -0.08; TCGA KIRP -0.095; TCGA LGG -0.584; TCGA OV -0.184; TCGA SARC -0.116; TCGA THCA -0.218; TCGA STAD -0.11; TCGA UCEC -0.069
hsa-miR-9-5p
EHD4
9 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; SARC
MirTarget
TCGA BLCA -0.058; TCGA BRCA -0.054; TCGA ESCA -0.1; TCGA HNSC -0.119; TCGA LGG -0.612; TCGA LUAD -0.053; TCGA LUSC -0.118; TCGA PRAD -0.051; TCGA SARC -0.082
hsa-miR-9-5p
LHFPL2
9 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LGG; LUSC; OV; PRAD
MirTarget
TCGA BLCA -0.074; TCGA CESC -0.07; TCGA ESCA -0.089; TCGA HNSC -0.085; TCGA KIRP -0.054; TCGA LGG -0.655; TCGA LUSC -0.17; TCGA OV -0.06; TCGA PRAD -0.062
hsa-miR-9-5p
KCTD12
10 cancers: BLCA; BRCA; CESC; HNSC; LGG; LUAD; LUSC; OV; PRAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.124; TCGA BRCA -0.092; TCGA CESC -0.055; TCGA HNSC -0.152; TCGA LGG -0.482; TCGA LUAD -0.11; TCGA LUSC -0.274; TCGA OV -0.247; TCGA PRAD -0.064; TCGA UCEC -0.23
hsa-miR-9-5p
PDGFRB
10 cancers: BLCA; BRCA; CESC; HNSC; LGG; LUAD; LUSC; OV; PRAD; SARC
MirTarget; miRNATAP
TCGA BLCA -0.128; TCGA BRCA -0.096; TCGA CESC -0.077; TCGA HNSC -0.102; TCGA LGG -0.368; TCGA LUAD -0.06; TCGA LUSC -0.172; TCGA OV -0.135; TCGA PRAD -0.057; TCGA SARC -0.139
hsa-miR-9-5p
SLC9A1
11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; SARC; THCA; STAD
MirTarget
TCGA BLCA -0.067; TCGA BRCA -0.057; TCGA COAD -0.076; TCGA ESCA -0.105; TCGA HNSC -0.097; TCGA LGG -0.703; TCGA LUAD -0.067; TCGA LUSC -0.052; TCGA SARC -0.067; TCGA THCA -0.059; TCGA STAD -0.076
hsa-miR-9-5p
ANO6
9 cancers: BLCA; BRCA; CESC; HNSC; LGG; LUSC; PRAD; THCA; UCEC
MirTarget
TCGA BLCA -0.05; TCGA BRCA -0.078; TCGA CESC -0.058; TCGA HNSC -0.11; TCGA LGG -0.559; TCGA LUSC -0.112; TCGA PRAD -0.13; TCGA THCA -0.097; TCGA UCEC -0.078
hsa-miR-9-5p
COL4A2
10 cancers: BLCA; CESC; HNSC; KIRC; LGG; LUSC; OV; PRAD; THCA; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.066; TCGA CESC -0.101; TCGA HNSC -0.056; TCGA KIRC -0.101; TCGA LGG -1.111; TCGA LUSC -0.089; TCGA OV -0.093; TCGA PRAD -0.053; TCGA THCA -0.054; TCGA UCEC -0.063
hsa-miR-9-5p
FOXP1
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; SARC
MirTarget; miRNATAP
TCGA BLCA -0.061; TCGA BRCA -0.127; TCGA CESC -0.084; TCGA COAD -0.065; TCGA ESCA -0.122; TCGA HNSC -0.073; TCGA LUAD -0.088; TCGA LUSC -0.18; TCGA PAAD -0.075; TCGA SARC -0.078
hsa-miR-9-5p
COL15A1
9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LGG; OV; PRAD; SARC
MirTarget; miRNATAP
TCGA BLCA -0.143; TCGA BRCA -0.05; TCGA ESCA -0.142; TCGA HNSC -0.057; TCGA KIRC -0.114; TCGA LGG -1.527; TCGA OV -0.072; TCGA PRAD -0.076; TCGA SARC -0.129
hsa-miR-9-5p
TMEM63A
9 cancers: BLCA; CESC; COAD; ESCA; KIRP; LGG; LIHC; LUSC; STAD
MirTarget
TCGA BLCA -0.089; TCGA CESC -0.129; TCGA COAD -0.094; TCGA ESCA -0.222; TCGA KIRP -0.053; TCGA LGG -0.334; TCGA LIHC -0.058; TCGA LUSC -0.067; TCGA STAD -0.141
hsa-miR-9-5p
FLRT3
12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.144; TCGA BRCA -0.258; TCGA CESC -0.241; TCGA COAD -0.173; TCGA ESCA -0.199; TCGA HNSC -0.631; TCGA LIHC -0.157; TCGA LUAD -0.236; TCGA LUSC -0.494; TCGA THCA -0.154; TCGA STAD -0.132; TCGA UCEC -0.265
hsa-miR-9-5p
CBX7
9 cancers: BLCA; BRCA; KIRC; LIHC; LUAD; LUSC; OV; SARC; UCEC
MirTarget
TCGA BLCA -0.077; TCGA BRCA -0.131; TCGA KIRC -0.056; TCGA LIHC -0.056; TCGA LUAD -0.148; TCGA LUSC -0.157; TCGA OV -0.11; TCGA SARC -0.088; TCGA UCEC -0.173
hsa-miR-9-5p
FLI1
12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PRAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.069; TCGA BRCA -0.07; TCGA CESC -0.134; TCGA ESCA -0.076; TCGA HNSC -0.062; TCGA KIRC -0.092; TCGA LGG -0.29; TCGA LUAD -0.146; TCGA LUSC -0.341; TCGA OV -0.098; TCGA PRAD -0.052; TCGA UCEC -0.099
hsa-miR-9-5p
ZEB2
10 cancers: BLCA; BRCA; CESC; HNSC; LUAD; LUSC; OV; PRAD; SARC; UCEC
MirTarget
TCGA BLCA -0.11; TCGA BRCA -0.07; TCGA CESC -0.058; TCGA HNSC -0.105; TCGA LUAD -0.119; TCGA LUSC -0.3; TCGA OV -0.139; TCGA PRAD -0.124; TCGA SARC -0.086; TCGA UCEC -0.115
hsa-miR-9-5p
THEMIS
9 cancers: BLCA; KIRC; LGG; LUAD; LUSC; OV; PRAD; SARC; UCEC
MirTarget
TCGA BLCA -0.113; TCGA KIRC -0.128; TCGA LGG -0.66; TCGA LUAD -0.098; TCGA LUSC -0.153; TCGA OV -0.219; TCGA PRAD -0.098; TCGA SARC -0.234; TCGA UCEC -0.135
hsa-miR-9-5p
SLCO2B1
14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PRAD; SARC; UCEC
MirTarget
TCGA BLCA -0.16; TCGA BRCA -0.064; TCGA CESC -0.08; TCGA ESCA -0.168; TCGA HNSC -0.113; TCGA KIRC -0.121; TCGA KIRP -0.064; TCGA LGG -0.169; TCGA LUAD -0.145; TCGA LUSC -0.369; TCGA OV -0.127; TCGA PRAD -0.05; TCGA SARC -0.233; TCGA UCEC -0.119
hsa-miR-9-5p
MSR1
10 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; SARC; UCEC
mirMAP
TCGA BLCA -0.11; TCGA HNSC -0.061; TCGA KIRC -0.113; TCGA KIRP -0.092; TCGA LGG -0.883; TCGA LUAD -0.126; TCGA LUSC -0.428; TCGA OV -0.149; TCGA SARC -0.19; TCGA UCEC -0.091
hsa-miR-9-5p
CD84
12 cancers: BLCA; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PRAD; SARC; UCEC
mirMAP
TCGA BLCA -0.129; TCGA ESCA -0.116; TCGA HNSC -0.078; TCGA KIRC -0.175; TCGA KIRP -0.086; TCGA LGG -0.594; TCGA LUAD -0.091; TCGA LUSC -0.256; TCGA OV -0.129; TCGA PRAD -0.15; TCGA SARC -0.2; TCGA UCEC -0.074
hsa-miR-9-5p
PLXNA2
10 cancers: BLCA; COAD; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD
mirMAP
TCGA BLCA -0.109; TCGA COAD -0.071; TCGA KIRC -0.098; TCGA LGG -0.125; TCGA LUAD -0.174; TCGA LUSC -0.134; TCGA PAAD -0.122; TCGA PRAD -0.056; TCGA THCA -0.1; TCGA STAD -0.074
hsa-miR-9-5p
TNS1
10 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LUAD; LUSC; OV; PRAD; UCEC
mirMAP
TCGA BLCA -0.189; TCGA BRCA -0.144; TCGA CESC -0.15; TCGA HNSC -0.08; TCGA KIRC -0.068; TCGA LUAD -0.189; TCGA LUSC -0.302; TCGA OV -0.144; TCGA PRAD -0.092; TCGA UCEC -0.137
hsa-miR-9-5p
FAM78A
10 cancers: BLCA; CESC; ESCA; KIRC; LGG; LUAD; LUSC; OV; SARC; UCEC
mirMAP
TCGA BLCA -0.073; TCGA CESC -0.092; TCGA ESCA -0.109; TCGA KIRC -0.161; TCGA LGG -0.397; TCGA LUAD -0.084; TCGA LUSC -0.194; TCGA OV -0.072; TCGA SARC -0.093; TCGA UCEC -0.094
hsa-miR-9-5p
WDFY4
9 cancers: BLCA; BRCA; KIRC; KIRP; LGG; LUAD; LUSC; OV; SARC
mirMAP
TCGA BLCA -0.142; TCGA BRCA -0.05; TCGA KIRC -0.184; TCGA KIRP -0.111; TCGA LGG -0.609; TCGA LUAD -0.136; TCGA LUSC -0.344; TCGA OV -0.162; TCGA SARC -0.197
hsa-miR-9-5p
GLIPR1
9 cancers: BLCA; CESC; HNSC; LGG; LUAD; LUSC; OV; SARC; UCEC
mirMAP
TCGA BLCA -0.122; TCGA CESC -0.126; TCGA HNSC -0.182; TCGA LGG -0.558; TCGA LUAD -0.051; TCGA LUSC -0.208; TCGA OV -0.099; TCGA SARC -0.148; TCGA UCEC -0.141
hsa-miR-9-5p
JDP2
11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; UCEC
mirMAP
TCGA BLCA -0.088; TCGA BRCA -0.112; TCGA CESC -0.105; TCGA ESCA -0.059; TCGA HNSC -0.089; TCGA KIRC -0.064; TCGA LGG -0.175; TCGA LIHC -0.073; TCGA LUAD -0.077; TCGA LUSC -0.178; TCGA UCEC -0.071
hsa-miR-9-5p
COL8A1
11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LUAD; LUSC; OV; PRAD; THCA
mirMAP
TCGA BLCA -0.11; TCGA BRCA -0.087; TCGA CESC -0.131; TCGA HNSC -0.088; TCGA KIRC -0.146; TCGA LGG -1.921; TCGA LUAD -0.079; TCGA LUSC -0.261; TCGA OV -0.384; TCGA PRAD -0.121; TCGA THCA -0.103
hsa-miR-9-5p
SETD7
10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUSC; OV; PRAD; SARC; UCEC
mirMAP
TCGA BLCA -0.051; TCGA BRCA -0.067; TCGA HNSC -0.071; TCGA KIRC -0.059; TCGA KIRP -0.058; TCGA LUSC -0.066; TCGA OV -0.117; TCGA PRAD -0.085; TCGA SARC -0.074; TCGA UCEC -0.08
hsa-miR-9-5p
ARHGAP26
10 cancers: BLCA; CESC; COAD; ESCA; KIRC; LGG; LUAD; LUSC; OV; STAD
mirMAP
TCGA BLCA -0.055; TCGA CESC -0.137; TCGA COAD -0.085; TCGA ESCA -0.209; TCGA KIRC -0.076; TCGA LGG -0.281; TCGA LUAD -0.08; TCGA LUSC -0.091; TCGA OV -0.131; TCGA STAD -0.084
hsa-miR-9-5p
TACC1
9 cancers: BLCA; BRCA; LGG; LUAD; LUSC; OV; PRAD; SARC; UCEC
mirMAP
TCGA BLCA -0.129; TCGA BRCA -0.065; TCGA LGG -0.116; TCGA LUAD -0.114; TCGA LUSC -0.185; TCGA OV -0.091; TCGA PRAD -0.084; TCGA SARC -0.065; TCGA UCEC -0.068
hsa-miR-9-5p
GNAQ
9 cancers: BLCA; COAD; ESCA; LUAD; LUSC; OV; PRAD; THCA; STAD
mirMAP
TCGA BLCA -0.053; TCGA COAD -0.063; TCGA ESCA -0.093; TCGA LUAD -0.102; TCGA LUSC -0.145; TCGA OV -0.087; TCGA PRAD -0.06; TCGA THCA -0.074; TCGA STAD -0.053
hsa-miR-9-5p
KCNMA1
10 cancers: BLCA; BRCA; KIRC; LGG; LIHC; LUAD; LUSC; OV; PRAD; UCEC
mirMAP; miRNATAP
TCGA BLCA -0.106; TCGA BRCA -0.198; TCGA KIRC -0.151; TCGA LGG -0.303; TCGA LIHC -0.077; TCGA LUAD -0.077; TCGA LUSC -0.152; TCGA OV -0.192; TCGA PRAD -0.121; TCGA UCEC -0.089
hsa-miR-9-5p
GBP4
12 cancers: BLCA; CESC; ESCA; KIRC; LGG; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.138; TCGA CESC -0.128; TCGA ESCA -0.126; TCGA KIRC -0.093; TCGA LGG -0.505; TCGA LUAD -0.083; TCGA LUSC -0.25; TCGA OV -0.119; TCGA PRAD -0.07; TCGA SARC -0.135; TCGA STAD -0.162; TCGA UCEC -0.152
hsa-miR-9-5p
SNED1
10 cancers: BLCA; BRCA; CESC; KIRC; LGG; LIHC; LUAD; LUSC; OV; UCEC
mirMAP
TCGA BLCA -0.098; TCGA BRCA -0.174; TCGA CESC -0.153; TCGA KIRC -0.113; TCGA LGG -0.412; TCGA LIHC -0.13; TCGA LUAD -0.151; TCGA LUSC -0.252; TCGA OV -0.126; TCGA UCEC -0.106
hsa-miR-9-5p
SHE
9 cancers: BLCA; BRCA; KIRC; LGG; LUAD; LUSC; PRAD; THCA; UCEC
mirMAP
TCGA BLCA -0.073; TCGA BRCA -0.129; TCGA KIRC -0.062; TCGA LGG -0.219; TCGA LUAD -0.273; TCGA LUSC -0.381; TCGA PRAD -0.105; TCGA THCA -0.178; TCGA UCEC -0.093
hsa-miR-9-5p
HEG1
10 cancers: BLCA; BRCA; HNSC; LGG; LUAD; LUSC; OV; PRAD; SARC; THCA
mirMAP
TCGA BLCA -0.114; TCGA BRCA -0.08; TCGA HNSC -0.109; TCGA LGG -0.264; TCGA LUAD -0.121; TCGA LUSC -0.216; TCGA OV -0.176; TCGA PRAD -0.104; TCGA SARC -0.132; TCGA THCA -0.093
hsa-miR-9-5p
FAM26E
12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; OV; PRAD; SARC; UCEC
mirMAP
TCGA BLCA -0.108; TCGA BRCA -0.102; TCGA CESC -0.082; TCGA ESCA -0.108; TCGA HNSC -0.187; TCGA LGG -0.551; TCGA LUAD -0.052; TCGA LUSC -0.15; TCGA OV -0.148; TCGA PRAD -0.106; TCGA SARC -0.118; TCGA UCEC -0.077
hsa-miR-9-5p
HRH1
12 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LGG; LUSC; OV; PAAD; SARC; THCA; UCEC
mirMAP
TCGA BLCA -0.083; TCGA CESC -0.138; TCGA ESCA -0.109; TCGA HNSC -0.17; TCGA KIRC -0.05; TCGA LGG -0.542; TCGA LUSC -0.177; TCGA OV -0.201; TCGA PAAD -0.119; TCGA SARC -0.165; TCGA THCA -0.162; TCGA UCEC -0.213
hsa-miR-9-5p
PARVA
9 cancers: BLCA; BRCA; CESC; HNSC; LGG; LUAD; LUSC; PRAD; SARC
mirMAP
TCGA BLCA -0.103; TCGA BRCA -0.065; TCGA CESC -0.147; TCGA HNSC -0.106; TCGA LGG -0.237; TCGA LUAD -0.076; TCGA LUSC -0.117; TCGA PRAD -0.081; TCGA SARC -0.06
hsa-miR-9-5p
STARD13
11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PRAD
miRNATAP
TCGA BLCA -0.124; TCGA BRCA -0.162; TCGA CESC -0.154; TCGA ESCA -0.126; TCGA HNSC -0.161; TCGA LGG -0.363; TCGA LIHC -0.098; TCGA LUAD -0.141; TCGA LUSC -0.31; TCGA OV -0.072; TCGA PRAD -0.082
hsa-miR-9-5p
ERG
10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV
miRNATAP
TCGA BLCA -0.067; TCGA BRCA -0.117; TCGA ESCA -0.086; TCGA HNSC -0.099; TCGA KIRC -0.069; TCGA LGG -0.148; TCGA LIHC -0.071; TCGA LUAD -0.159; TCGA LUSC -0.311; TCGA OV -0.086
hsa-miR-9-5p
NR5A2
9 cancers: BLCA; BRCA; CESC; ESCA; LGG; LIHC; LUAD; LUSC; PRAD
miRNATAP
TCGA BLCA -0.06; TCGA BRCA -0.105; TCGA CESC -0.103; TCGA ESCA -0.285; TCGA LGG -0.584; TCGA LIHC -0.077; TCGA LUAD -0.105; TCGA LUSC -0.253; TCGA PRAD -0.086
hsa-miR-9-5p
FYCO1
11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; OV; PRAD; UCEC
miRNATAP
TCGA BLCA -0.111; TCGA BRCA -0.119; TCGA CESC -0.064; TCGA ESCA -0.066; TCGA HNSC -0.113; TCGA LGG -0.516; TCGA LUAD -0.091; TCGA LUSC -0.154; TCGA OV -0.053; TCGA PRAD -0.107; TCGA UCEC -0.053
hsa-miR-9-5p
CPEB2
10 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LGG; LUSC; OV; THCA
miRNATAP
TCGA BLCA -0.069; TCGA BRCA -0.195; TCGA CESC -0.052; TCGA COAD -0.065; TCGA HNSC -0.216; TCGA KIRC -0.057; TCGA LGG -0.463; TCGA LUSC -0.161; TCGA OV -0.125; TCGA THCA -0.051
hsa-miR-9-5p
NRP1
10 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; SARC
miRNATAP
TCGA BLCA -0.055; TCGA BRCA -0.057; TCGA HNSC -0.16; TCGA KIRC -0.092; TCGA LGG -0.551; TCGA LIHC -0.059; TCGA LUAD -0.062; TCGA LUSC -0.243; TCGA OV -0.074; TCGA SARC -0.06
hsa-miR-9-5p
MYO1C
13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA
miRNATAP
TCGA BLCA -0.087; TCGA BRCA -0.072; TCGA CESC -0.096; TCGA ESCA -0.052; TCGA HNSC -0.12; TCGA LGG -0.5; TCGA LUAD -0.061; TCGA LUSC -0.124; TCGA OV -0.065; TCGA PAAD -0.071; TCGA PRAD -0.077; TCGA SARC -0.052; TCGA THCA -0.062
hsa-miR-9-5p
TGFBR2
13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; UCEC
miRNATAP
TCGA BLCA -0.12; TCGA BRCA -0.12; TCGA CESC -0.159; TCGA ESCA -0.191; TCGA HNSC -0.233; TCGA LGG -0.687; TCGA LIHC -0.076; TCGA LUAD -0.173; TCGA LUSC -0.356; TCGA OV -0.118; TCGA PRAD -0.122; TCGA SARC -0.122; TCGA UCEC -0.129
hsa-miR-9-5p
CPEB4
9 cancers: BLCA; BRCA; CESC; HNSC; LIHC; LUAD; LUSC; OV; PRAD
miRNATAP
TCGA BLCA -0.061; TCGA BRCA -0.099; TCGA CESC -0.069; TCGA HNSC -0.166; TCGA LIHC -0.058; TCGA LUAD -0.079; TCGA LUSC -0.155; TCGA OV -0.073; TCGA PRAD -0.079
hsa-miR-9-5p
PLEKHA6
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; OV; PAAD; PRAD; STAD; UCEC
miRNATAP
TCGA BLCA -0.084; TCGA BRCA -0.075; TCGA CESC -0.216; TCGA COAD -0.097; TCGA ESCA -0.364; TCGA LIHC -0.056; TCGA OV -0.076; TCGA PAAD -0.136; TCGA PRAD -0.092; TCGA STAD -0.097; TCGA UCEC -0.113
hsa-miR-9-5p
TMEM200A
13 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PRAD; SARC; UCEC
miRNATAP
TCGA BLCA -0.119; TCGA CESC -0.176; TCGA ESCA -0.124; TCGA HNSC -0.064; TCGA KIRC -0.174; TCGA KIRP -0.126; TCGA LGG -0.87; TCGA LUAD -0.052; TCGA LUSC -0.188; TCGA OV -0.157; TCGA PRAD -0.089; TCGA SARC -0.156; TCGA UCEC -0.097
hsa-miR-9-5p
WIPF1
10 cancers: BLCA; CESC; KIRC; LGG; LUAD; LUSC; OV; PRAD; SARC; UCEC
miRNATAP
TCGA BLCA -0.086; TCGA CESC -0.132; TCGA KIRC -0.114; TCGA LGG -0.116; TCGA LUAD -0.054; TCGA LUSC -0.173; TCGA OV -0.075; TCGA PRAD -0.057; TCGA SARC -0.055; TCGA UCEC -0.11
hsa-miR-9-5p
CMTM6
9 cancers: BLCA; CESC; LGG; LIHC; LUSC; OV; PAAD; THCA; STAD
miRNATAP
TCGA BLCA -0.058; TCGA CESC -0.057; TCGA LGG -0.409; TCGA LIHC -0.052; TCGA LUSC -0.05; TCGA OV -0.079; TCGA PAAD -0.074; TCGA THCA -0.072; TCGA STAD -0.053
hsa-miR-9-5p
TLN1
11 cancers: BLCA; CESC; HNSC; KIRC; LGG; LUAD; LUSC; OV; PRAD; SARC; UCEC
miRNATAP
TCGA BLCA -0.065; TCGA CESC -0.063; TCGA HNSC -0.116; TCGA KIRC -0.051; TCGA LGG -0.229; TCGA LUAD -0.068; TCGA LUSC -0.113; TCGA OV -0.066; TCGA PRAD -0.088; TCGA SARC -0.068; TCGA UCEC -0.063
hsa-miR-9-5p
RHOJ
11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; OV; PRAD; UCEC
miRNATAP
TCGA BLCA -0.133; TCGA BRCA -0.09; TCGA CESC -0.088; TCGA ESCA -0.117; TCGA HNSC -0.099; TCGA LGG -0.431; TCGA LUAD -0.133; TCGA LUSC -0.345; TCGA OV -0.059; TCGA PRAD -0.1; TCGA UCEC -0.058
hsa-miR-9-5p
MAF
9 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; UCEC
miRNATAP
TCGA BLCA -0.075; TCGA HNSC -0.185; TCGA KIRC -0.125; TCGA KIRP -0.149; TCGA LGG -0.32; TCGA LUAD -0.057; TCGA LUSC -0.062; TCGA OV -0.158; TCGA UCEC -0.118
hsa-miR-9-5p
AMOTL2
11 cancers: BLCA; BRCA; CESC; HNSC; LIHC; LUAD; LUSC; OV; PRAD; STAD; UCEC
miRNATAP
TCGA BLCA -0.093; TCGA BRCA -0.082; TCGA CESC -0.056; TCGA HNSC -0.103; TCGA LIHC -0.089; TCGA LUAD -0.052; TCGA LUSC -0.108; TCGA OV -0.058; TCGA PRAD -0.088; TCGA STAD -0.07; TCGA UCEC -0.171
hsa-miR-9-5p
YAP1
10 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; THCA; STAD
miRNATAP
TCGA BLCA -0.077; TCGA BRCA -0.051; TCGA HNSC -0.122; TCGA LGG -0.677; TCGA LIHC -0.069; TCGA LUAD -0.073; TCGA LUSC -0.067; TCGA PRAD -0.114; TCGA THCA -0.092; TCGA STAD -0.071
hsa-miR-9-5p
PDE7B
12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; THCA; UCEC
miRNATAP
TCGA BLCA -0.094; TCGA BRCA -0.081; TCGA CESC -0.144; TCGA ESCA -0.102; TCGA HNSC -0.084; TCGA LGG -0.364; TCGA LIHC -0.139; TCGA LUAD -0.134; TCGA LUSC -0.196; TCGA PRAD -0.091; TCGA THCA -0.122; TCGA UCEC -0.131
hsa-miR-9-5p
RCAN2
9 cancers: BLCA; BRCA; HNSC; LGG; LUAD; LUSC; PRAD; SARC; UCEC
miRNATAP
TCGA BLCA -0.122; TCGA BRCA -0.081; TCGA HNSC -0.129; TCGA LGG -0.52; TCGA LUAD -0.136; TCGA LUSC -0.286; TCGA PRAD -0.091; TCGA SARC -0.196; TCGA UCEC -0.113
hsa-miR-9-5p
EPAS1
11 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PRAD; SARC
miRNATAP
TCGA BLCA -0.096; TCGA BRCA -0.104; TCGA ESCA -0.062; TCGA HNSC -0.103; TCGA KIRC -0.087; TCGA LIHC -0.072; TCGA LUAD -0.132; TCGA LUSC -0.368; TCGA OV -0.077; TCGA PRAD -0.072; TCGA SARC -0.173
hsa-miR-9-5p
KIF13B
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; THCA; STAD
miRNATAP
TCGA BLCA -0.052; TCGA BRCA -0.229; TCGA CESC -0.092; TCGA COAD -0.097; TCGA ESCA -0.308; TCGA HNSC -0.105; TCGA LGG -0.151; TCGA LUAD -0.093; TCGA LUSC -0.171; TCGA OV -0.063; TCGA PAAD -0.084; TCGA THCA -0.075; TCGA STAD -0.08
hsa-miR-9-5p
ADCY9
10 cancers: BLCA; BRCA; CESC; HNSC; LGG; LUAD; LUSC; OV; PRAD; UCEC
miRNATAP
TCGA BLCA -0.066; TCGA BRCA -0.129; TCGA CESC -0.064; TCGA HNSC -0.069; TCGA LGG -0.414; TCGA LUAD -0.104; TCGA LUSC -0.164; TCGA OV -0.097; TCGA PRAD -0.07; TCGA UCEC -0.238
hsa-miR-9-5p
ABCA1
9 cancers: BLCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; THCA
miRNATAP
TCGA BLCA -0.096; TCGA HNSC -0.113; TCGA KIRC -0.089; TCGA KIRP -0.082; TCGA LIHC -0.071; TCGA LUAD -0.064; TCGA LUSC -0.078; TCGA OV -0.098; TCGA THCA -0.176
hsa-miR-9-5p
AXL
10 cancers: BLCA; BRCA; CESC; HNSC; LGG; LUAD; LUSC; OV; SARC; UCEC
miRNATAP
TCGA BLCA -0.194; TCGA BRCA -0.112; TCGA CESC -0.103; TCGA HNSC -0.137; TCGA LGG -0.196; TCGA LUAD -0.101; TCGA LUSC -0.244; TCGA OV -0.099; TCGA SARC -0.084; TCGA UCEC -0.136
hsa-miR-9-5p
ANXA2
9 cancers: BLCA; COAD; ESCA; HNSC; LGG; LUSC; OV; SARC; STAD
miRNATAP
TCGA BLCA -0.056; TCGA COAD -0.097; TCGA ESCA -0.094; TCGA HNSC -0.103; TCGA LGG -1.12; TCGA LUSC -0.053; TCGA OV -0.121; TCGA SARC -0.1; TCGA STAD -0.172
hsa-miR-9-5p
TSPAN15
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUSC; PAAD; SARC; STAD
miRNATAP
TCGA BLCA -0.11; TCGA BRCA -0.188; TCGA CESC -0.064; TCGA COAD -0.121; TCGA ESCA -0.228; TCGA LUSC -0.092; TCGA PAAD -0.131; TCGA SARC -0.069; TCGA STAD -0.097
hsa-miR-9-5p
FBXL3
9 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; UCEC
miRNATAP
TCGA BLCA -0.064; TCGA BRCA -0.078; TCGA HNSC -0.054; TCGA LGG -0.068; TCGA LIHC -0.054; TCGA LUAD -0.075; TCGA LUSC -0.086; TCGA OV -0.067; TCGA UCEC -0.078
hsa-miR-9-5p
RPS6KA2
9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; PRAD; THCA
miRNATAP
TCGA BLCA -0.077; TCGA BRCA -0.055; TCGA CESC -0.179; TCGA ESCA -0.141; TCGA HNSC -0.106; TCGA LUAD -0.131; TCGA LUSC -0.29; TCGA PRAD -0.067; TCGA THCA -0.127
hsa-miR-9-5p
CCND1
11 cancers: BRCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; THCA; STAD
miRNAWalker2 validate
TCGA BRCA -0.162; TCGA HNSC -0.135; TCGA KIRC -0.164; TCGA KIRP -0.1; TCGA LIHC -0.137; TCGA LUAD -0.074; TCGA LUSC -0.139; TCGA OV -0.163; TCGA PAAD -0.156; TCGA THCA -0.241; TCGA STAD -0.139
hsa-miR-9-5p
CCNG1
11 cancers: BRCA; CESC; COAD; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; THCA; STAD
miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP
TCGA BRCA -0.074; TCGA CESC -0.066; TCGA COAD -0.099; TCGA KIRC -0.065; TCGA KIRP -0.067; TCGA LGG -0.228; TCGA LUAD -0.085; TCGA LUSC -0.074; TCGA PRAD -0.054; TCGA THCA -0.072; TCGA STAD -0.064
hsa-miR-9-5p
FRMD4B
12 cancers: BRCA; CESC; COAD; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD
miRNAWalker2 validate
TCGA BRCA -0.076; TCGA CESC -0.056; TCGA COAD -0.061; TCGA HNSC -0.14; TCGA KIRC -0.052; TCGA LGG -0.649; TCGA LIHC -0.066; TCGA LUAD -0.111; TCGA LUSC -0.112; TCGA OV -0.145; TCGA PAAD -0.088; TCGA PRAD -0.051
hsa-miR-9-5p
EMB
9 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV
MirTarget; miRNATAP
TCGA BRCA -0.105; TCGA CESC -0.187; TCGA ESCA -0.181; TCGA HNSC -0.127; TCGA KIRC -0.086; TCGA LGG -0.842; TCGA LUAD -0.081; TCGA LUSC -0.204; TCGA OV -0.188
hsa-miR-9-5p
PALMD
9 cancers: BRCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC
MirTarget; miRNATAP
TCGA BRCA -0.131; TCGA HNSC -0.213; TCGA LGG -0.726; TCGA LIHC -0.148; TCGA LUAD -0.177; TCGA LUSC -0.258; TCGA OV -0.133; TCGA PRAD -0.073; TCGA SARC -0.085
hsa-miR-9-5p
PTPRB
11 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PRAD; SARC; THCA
mirMAP; miRNATAP
TCGA BRCA -0.162; TCGA CESC -0.137; TCGA ESCA -0.182; TCGA HNSC -0.062; TCGA KIRC -0.091; TCGA LIHC -0.098; TCGA LUAD -0.186; TCGA LUSC -0.401; TCGA PRAD -0.114; TCGA SARC -0.064; TCGA THCA -0.069
hsa-miR-9-5p
SHROOM3
11 cancers: BRCA; CESC; COAD; ESCA; LGG; LUAD; LUSC; OV; PRAD; THCA; STAD
mirMAP; miRNATAP
TCGA BRCA -0.069; TCGA CESC -0.204; TCGA COAD -0.069; TCGA ESCA -0.227; TCGA LGG -1.5; TCGA LUAD -0.086; TCGA LUSC -0.176; TCGA OV -0.107; TCGA PRAD -0.096; TCGA THCA -0.085; TCGA STAD -0.151
hsa-miR-9-5p
MTHFR
9 cancers: BRCA; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; THCA; UCEC
mirMAP
TCGA BRCA -0.094; TCGA ESCA -0.075; TCGA HNSC -0.052; TCGA KIRC -0.054; TCGA LGG -0.227; TCGA LUAD -0.061; TCGA LUSC -0.118; TCGA THCA -0.097; TCGA UCEC -0.068
hsa-miR-9-5p
AR
9 cancers: BRCA; CESC; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PRAD
miRNATAP
TCGA BRCA -0.477; TCGA CESC -0.162; TCGA HNSC -0.105; TCGA KIRC -0.169; TCGA LGG -0.661; TCGA LIHC -0.211; TCGA LUAD -0.175; TCGA LUSC -0.33; TCGA PRAD -0.208
hsa-miR-9-5p
SH3BGRL2
9 cancers: BRCA; COAD; ESCA; LIHC; LUAD; LUSC; PRAD; THCA; STAD
miRNATAP
TCGA BRCA -0.099; TCGA COAD -0.08; TCGA ESCA -0.231; TCGA LIHC -0.113; TCGA LUAD -0.085; TCGA LUSC -0.139; TCGA PRAD -0.091; TCGA THCA -0.13; TCGA STAD -0.075
hsa-miR-9-5p
SLC1A1
9 cancers: BRCA; CESC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; STAD
miRNATAP
TCGA BRCA -0.264; TCGA CESC -0.147; TCGA KIRC -0.121; TCGA KIRP -0.094; TCGA LIHC -0.117; TCGA LUAD -0.174; TCGA LUSC -0.384; TCGA PRAD -0.141; TCGA STAD -0.167
hsa-miR-9-5p
DPP4
14 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PRAD; SARC; THCA; UCEC
miRNATAP
TCGA BRCA -0.093; TCGA CESC -0.197; TCGA ESCA -0.243; TCGA HNSC -0.103; TCGA KIRC -0.074; TCGA KIRP -0.202; TCGA LGG -1.085; TCGA LUAD -0.102; TCGA LUSC -0.357; TCGA OV -0.241; TCGA PRAD -0.111; TCGA SARC -0.245; TCGA THCA -0.44; TCGA UCEC -0.355
hsa-miR-9-5p
P4HA2
9 cancers: CESC; COAD; HNSC; KIRC; KIRP; LGG; OV; SARC; THCA
miRNAWalker2 validate; MirTarget; miRNATAP
TCGA CESC -0.057; TCGA COAD -0.069; TCGA HNSC -0.14; TCGA KIRC -0.093; TCGA KIRP -0.066; TCGA LGG -0.946; TCGA OV -0.073; TCGA SARC -0.108; TCGA THCA -0.205
hsa-miR-9-5p
SLC39A14
9 cancers: CESC; COAD; ESCA; KIRC; LIHC; PAAD; PRAD; SARC; STAD
miRNAWalker2 validate; miRNATAP
TCGA CESC -0.106; TCGA COAD -0.086; TCGA ESCA -0.163; TCGA KIRC -0.067; TCGA LIHC -0.057; TCGA PAAD -0.095; TCGA PRAD -0.071; TCGA SARC -0.135; TCGA STAD -0.116
hsa-miR-9-5p
SPTBN1
11 cancers: CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD
miRNAWalker2 validate
TCGA CESC -0.069; TCGA ESCA -0.135; TCGA HNSC -0.054; TCGA KIRC -0.053; TCGA KIRP -0.059; TCGA LGG -0.084; TCGA LIHC -0.063; TCGA LUAD -0.09; TCGA LUSC -0.168; TCGA PRAD -0.095; TCGA STAD -0.073
hsa-miR-9-5p
ATP11A
10 cancers: CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; THCA
MirTarget; miRNATAP
TCGA CESC -0.125; TCGA ESCA -0.132; TCGA HNSC -0.073; TCGA KIRC -0.148; TCGA KIRP -0.073; TCGA LGG -0.239; TCGA LUAD -0.12; TCGA LUSC -0.225; TCGA OV -0.157; TCGA THCA -0.148
hsa-miR-9-5p
PRRG1
10 cancers: CESC; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PRAD; THCA; UCEC
mirMAP
TCGA CESC -0.153; TCGA ESCA -0.191; TCGA HNSC -0.252; TCGA LIHC -0.053; TCGA LUAD -0.096; TCGA LUSC -0.192; TCGA OV -0.12; TCGA PRAD -0.075; TCGA THCA -0.16; TCGA UCEC -0.17
hsa-miR-9-5p
SH2B3
10 cancers: CESC; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; SARC; UCEC
miRNATAP
TCGA CESC -0.089; TCGA ESCA -0.113; TCGA HNSC -0.057; TCGA KIRC -0.11; TCGA LGG -0.411; TCGA LUAD -0.072; TCGA LUSC -0.208; TCGA OV -0.073; TCGA SARC -0.075; TCGA UCEC -0.088
hsa-miR-9-5p
CD47
10 cancers: CESC; ESCA; HNSC; LGG; LUAD; LUSC; SARC; THCA; STAD; UCEC
miRNATAP
TCGA CESC -0.083; TCGA ESCA -0.128; TCGA HNSC -0.107; TCGA LGG -0.116; TCGA LUAD -0.073; TCGA LUSC -0.175; TCGA SARC -0.072; TCGA THCA -0.056; TCGA STAD -0.099; TCGA UCEC -0.153
hsa-miR-9-5p
RNF128
9 cancers: COAD; ESCA; HNSC; LGG; LUAD; LUSC; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA COAD -0.133; TCGA ESCA -0.302; TCGA HNSC -0.122; TCGA LGG -1.077; TCGA LUAD -0.111; TCGA LUSC -0.204; TCGA THCA -0.137; TCGA STAD -0.262; TCGA UCEC -0.152





Enriched cancer pathways of putative targets